Profiling the Inflammatory Cascade of COVID-19

计划入组 41 人 · 首次发布于 2024 年 7 月 19 日

Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma

计划入组 52 人 · 首次发布于 2020 年 2 月 11 日

Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.

计划入组 48 人 · 首次发布于 2022 年 7 月 19 日

CB-401 (Cascade)

cascade primed immune cells

CSC-900 series (Cascade)

Cascade Pharmaceuticals, Inc

China

Synlogic

United States

Celltrion, Inc.

South Korea

Matisse Pharmaceuticals Advances M6229 Sepsis Treatment with Positive 120-Hour Infusion Trial Results

Upstream Bio's Verekitug Shows Significant Efficacy in Phase 2 Severe Asthma Trial

Tezepelumab Enables Oral Corticosteroid Reduction in Severe Asthma Patients, WAYFINDER Trial Shows